During the past decade, Midas Multispeciality Hospital Pvt.Ltd. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midas Multispeciality Hospital Pvt.Ltd." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midas Multispeciality Hospital Pvt.Ltd." #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Midas Multispeciality Hospital Pvt.Ltd." are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (2 trials), "Chronic HBV Infection" (1 trials) and "Chronic Hepatitis B" (1 trials). Many other conditions were trialed in "Midas Multispeciality Hospital Pvt.Ltd." in a lesser frequency.

Most popular intervention types in "Midas Multispeciality Hospital Pvt.Ltd." are "Drug" (17 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Filgotinib" (4 trials), "Etrasimod" (3 trials), "Etrolizumab" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Midas Multispeciality Hospital Pvt.Ltd." are 18 trials for "All" genders.

Currently, there are NaN active trials in "Midas Multispeciality Hospital Pvt.Ltd.". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Midas Multispeciality Hospital Pvt.Ltd., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Midas Multispeciality Hospital Pvt.Ltd., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".